207 related articles for article (PubMed ID: 36823554)
1. Characteristics of vasculogenic mimicry and tumour to endothelial transdifferentiation in human glioblastoma: a systematic review.
Maddison K; Bowden NA; Graves MC; Tooney PA
BMC Cancer; 2023 Feb; 23(1):185. PubMed ID: 36823554
[TBL] [Abstract][Full Text] [Related]
2. Transdifferentiation of glioblastoma stem-like cells into mural cells drives vasculogenic mimicry in glioblastomas.
Scully S; Francescone R; Faibish M; Bentley B; Taylor SL; Oh D; Schapiro R; Moral L; Yan W; Shao R
J Neurosci; 2012 Sep; 32(37):12950-60. PubMed ID: 22973019
[TBL] [Abstract][Full Text] [Related]
3. Vasculogenic Mimicry Occurs at Low Levels in Primary and Recurrent Glioblastoma.
Maddison K; Faulkner S; Graves MC; Fay M; Bowden NA; Tooney PA
Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568738
[TBL] [Abstract][Full Text] [Related]
4. Glioma stem/progenitor cells contribute to neovascularization via transdifferentiation.
Dong J; Zhao Y; Huang Q; Fei X; Diao Y; Shen Y; Xiao H; Zhang T; Lan Q; Gu X
Stem Cell Rev Rep; 2011 Mar; 7(1):141-52. PubMed ID: 20697979
[TBL] [Abstract][Full Text] [Related]
5. Chitinase 3 like 1 (CHI3L1) promotes vasculogenic mimicry formation in cervical cancer.
Ngernyuang N; Shao R; Suwannarurk K; Limpaiboon T
Pathology; 2018 Apr; 50(3):293-297. PubMed ID: 29452694
[TBL] [Abstract][Full Text] [Related]
6. Tumor-associated macrophages induce vasculogenic mimicry of glioblastoma multiforme through cyclooxygenase-2 activation.
Rong X; Huang B; Qiu S; Li X; He L; Peng Y
Oncotarget; 2016 Dec; 7(51):83976-83986. PubMed ID: 27824617
[TBL] [Abstract][Full Text] [Related]
7. CD44 enhances tumor aggressiveness by promoting tumor cell plasticity.
Paulis YW; Huijbers EJ; van der Schaft DW; Soetekouw PM; Pauwels P; Tjan-Heijnen VC; Griffioen AW
Oncotarget; 2015 Aug; 6(23):19634-46. PubMed ID: 26189059
[TBL] [Abstract][Full Text] [Related]
8. Glioblastoma stem cell differentiation into endothelial cells evidenced through live-cell imaging.
Mei X; Chen YS; Chen FR; Xi SY; Chen ZP
Neuro Oncol; 2017 Aug; 19(8):1109-1118. PubMed ID: 28340100
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of transgelin blocks interleukin-8 utilization and suppresses vasculogenic mimicry in breast cancer cells.
Aikins AR; Kim M; Raymundo B; Kim CW
Exp Biol Med (Maywood); 2017 Mar; 242(6):573-583. PubMed ID: 28058861
[TBL] [Abstract][Full Text] [Related]
10. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells.
Ricci-Vitiani L; Pallini R; Biffoni M; Todaro M; Invernici G; Cenci T; Maira G; Parati EA; Stassi G; Larocca LM; De Maria R
Nature; 2010 Dec; 468(7325):824-8. PubMed ID: 21102434
[TBL] [Abstract][Full Text] [Related]
11. Tumour angiogenesis-Origin of blood vessels.
Krishna Priya S; Nagare RP; Sneha VS; Sidhanth C; Bindhya S; Manasa P; Ganesan TS
Int J Cancer; 2016 Aug; 139(4):729-35. PubMed ID: 26934471
[TBL] [Abstract][Full Text] [Related]
12. Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization.
Shao R; Taylor SL; Oh DS; Schwartz LM
Oncotarget; 2015 Dec; 6(38):40507-18. PubMed ID: 26439689
[TBL] [Abstract][Full Text] [Related]
13. A pilot study of vasculogenic mimicry immunohistochemical expression in hepatocellular carcinoma.
Guzman G; Cotler SJ; Lin AY; Maniotis AJ; Folberg R
Arch Pathol Lab Med; 2007 Dec; 131(12):1776-81. PubMed ID: 18081435
[TBL] [Abstract][Full Text] [Related]
14. CD133+ glioblastoma stem-like cells induce vascular mimicry in vivo.
Chiao MT; Yang YC; Cheng WY; Shen CC; Ko JL
Curr Neurovasc Res; 2011 Aug; 8(3):210-9. PubMed ID: 21675958
[TBL] [Abstract][Full Text] [Related]
15. CD31 and CD34 expression as immunohistochemical markers of endothelial transdifferentiation in human cutaneous melanoma.
Pisacane AM; Picciotto F; Risio M
Cell Oncol; 2007; 29(1):59-66. PubMed ID: 17429142
[TBL] [Abstract][Full Text] [Related]
16. Paradoxical role of β8 integrin on angiogenesis and vasculogenic mimicry in glioblastoma.
Liu Y; Xu X; Zhang Y; Mo Y; Sun X; Shu L; Ke Y
Cell Death Dis; 2022 Jun; 13(6):536. PubMed ID: 35676251
[TBL] [Abstract][Full Text] [Related]
17. Vascular mimicry in glioblastoma following anti-angiogenic and anti-20-HETE therapies.
Angara K; Rashid MH; Shankar A; Ara R; Iskander A; Borin TF; Jain M; Achyut BR; Arbab AS
Histol Histopathol; 2017 Sep; 32(9):917-928. PubMed ID: 27990624
[TBL] [Abstract][Full Text] [Related]
18. N6-Isopentenyladenosine Hinders the Vasculogenic Mimicry in Human Glioblastoma Cells through Src-120 Catenin Pathway Modulation and RhoA Activity Inhibition.
Pagano C; Navarra G; Pastorino O; Avilia G; Coppola L; Della Monica R; Chiariotti L; Florio T; Corsaro A; Torelli G; Caiazzo P; Gazzerro P; Bifulco M; Laezza C
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638872
[TBL] [Abstract][Full Text] [Related]
19. Vasculogenic mimicry: a novel target for glioma therapy.
Chen YS; Chen ZP
Chin J Cancer; 2014 Feb; 33(2):74-9. PubMed ID: 23816560
[TBL] [Abstract][Full Text] [Related]
20. FOXC2 promotes vasculogenic mimicry and resistance to anti-angiogenic therapy.
Cannell IG; Sawicka K; Pearsall I; Wild SA; Deighton L; Pearsall SM; Lerda G; Joud F; Khan S; Bruna A; Simpson KL; Mulvey CM; Nugent F; Qosaj F; Bressan D; ; Dive C; Caldas C; Hannon GJ
Cell Rep; 2023 Aug; 42(8):112791. PubMed ID: 37499655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
